192 related articles for article (PubMed ID: 28625798)
1. Melanoma patient imaging in the era of effective systemic therapies.
Stodell M; Thompson JF; Emmett L; Uren RF; Kapoor R; Saw RPM
Eur J Surg Oncol; 2017 Aug; 43(8):1517-1527. PubMed ID: 28625798
[TBL] [Abstract][Full Text] [Related]
2. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
[TBL] [Abstract][Full Text] [Related]
3. Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
Wagner T; Meyer N; Zerdoud S; Julian A; Chevreau C; Payoux P; Courbon F
Br J Dermatol; 2011 Jun; 164(6):1235-40. PubMed ID: 21332457
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy.
Wagner JD; Schauwecker D; Davidson D; Coleman JJ; Saxman S; Hutchins G; Love C; Hayes JT
J Clin Oncol; 1999 May; 17(5):1508-15. PubMed ID: 10334538
[TBL] [Abstract][Full Text] [Related]
5. The value of sentinel node mapping for staging melanoma.
Dijkstra B; Hill A; Kelly L; Prendegast M; McDermott E; O'Donnell M; Collins C; O'Higgins N
Ir Med J; 2001; 94(7):210-2. PubMed ID: 11693212
[TBL] [Abstract][Full Text] [Related]
6. The role of lymphoscintigraphy in the detection of lymph node drainage in melanoma.
Uren RF; Thompson JF; Howman-Giles R; Chung DK
Surg Oncol Clin N Am; 2006 Apr; 15(2):285-300. PubMed ID: 16632215
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for lymphoscintigraphy and F18 FDG PET scans in melanoma.
Uren RF; Howman-Giles R; Chung D; Thompson JF
J Surg Oncol; 2011 Sep; 104(4):405-19. PubMed ID: 21858836
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma.
Reintgen D; Rapaport D; Tanabe KK; Ross M
J Fla Med Assoc; 1997 Mar; 84(3):188-93. PubMed ID: 9143171
[TBL] [Abstract][Full Text] [Related]
9. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
Clark PB; Soo V; Kraas J; Shen P; Levine EA
Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694
[TBL] [Abstract][Full Text] [Related]
10. Targeted high-resolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma.
Sanki A; Uren RF; Moncrieff M; Tran KL; Scolyer RA; Lin HY; Thompson JF
J Clin Oncol; 2009 Nov; 27(33):5614-9. PubMed ID: 19786669
[TBL] [Abstract][Full Text] [Related]
11. [Management of patients with melanoma].
Robert C; Cavalcanti A; Kolb F; Sarfati B; Moya-Plana A; Tomasic G; Mateus C
Rev Prat; 2014 Jan; 64(1):75-80. PubMed ID: 24649552
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy.
Lee KK; Vetto JT; Mehrany K; Swanson NA
Clin Dermatol; 2004; 22(3):234-9. PubMed ID: 15262310
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous melanoma: a model to study cancer metastasis.
Leong SP; Gershenwald JE; Soong SJ; Schadendorf D; Tarhini AA; Agarwala S; Hauschild A; Soon CW; Daud A; Kashani-Sabet M
J Surg Oncol; 2011 May; 103(6):538-49. PubMed ID: 21480247
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of extensive initial staging procedure in intermediate/high-risk melanoma patients.
Vereecken P; Laporte M; Petein M; Steels E; Heenen M
J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):66-73. PubMed ID: 15649194
[TBL] [Abstract][Full Text] [Related]
15. Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.
Singh B; Ezziddin S; Palmedo H; Reinhardt M; Strunk H; Tüting T; Biersack HJ; Ahmadzadehfar H
Melanoma Res; 2008 Oct; 18(5):346-52. PubMed ID: 18781133
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography/computed tomography in melanoma.
Bourgeois AC; Chang TT; Fish LM; Bradley YC
Radiol Clin North Am; 2013 Sep; 51(5):865-79. PubMed ID: 24010910
[TBL] [Abstract][Full Text] [Related]
17. [Role of FDG PET-CT in cutaneous melanoma].
Nicol I; Chuto G; Gaudy-Marqueste C; Brenot-Rossi I; Grob JJ; Richard MA
Bull Cancer; 2008 Nov; 95(11):1089-101. PubMed ID: 19036682
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma.
Scheri RP; Essner R
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1105-10. PubMed ID: 16831081
[TBL] [Abstract][Full Text] [Related]
20. [Sonographic criteria for diagnosing sentinel node metastases in melanoma patients].
Ulrich J; van Akkooi AC; Eggermont AM; Voit CA
Ultraschall Med; 2015 Apr; 36(2):149-53. PubMed ID: 24764213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]